Reza Mahjoub

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Many new drugs, such as biologics and cancer drugs, are very costly. However, their effectiveness outside of clinical trial settings is often uncertain at the time they gain market approval. This uncertainty may reflect a lack of real-world outcomes data, as opposed to clinical trials data, for a typical patient population. A risk-sharing agreement is a(More)
  • 1